Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rexis Biotech logo — Groundbreaking Nanotechnology

Rexis Biotech

Groundbreaking Nanotechnology

Founded 2022 United States Las Vegas, United States 11 employees Biotechnology, Pharmaceutical +1

General Information

Company Name Rexis Biotech
Founded Year 2022
Location United States Las Vegas, United States +1
Employees 11
Industries Biotechnology, Pharmaceutical, Logistics and Delivery
Social

Get notified when Rexis Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rexis Biotech

Rexis Biotech is a biotech startup founded in 2022 that focuses on groundbreaking nanotechnology. Their proprietary drug delivery platform, Fused Polymorph Nano Fiber Technology™, enables brands to convert the rapidly growing industry of natural, plant-based consumables into products that are not only appealing but provide a superior taste. The company's vision is to revolutionize the consumables market by creating products that are not only better than existing options but also healthier. With a focus on biotechnology, pharmaceuticals, logistics, and delivery, Rexis Biotech aims to enhance the taste of consumables, optimize the effectiveness of medication, and elevate the experience of pharmaceuticals. While details about their headquarters, last investment, and investors are currently unavailable, their innovative approach to nanotechnology shows promise for improving various industries.

Taxonomy: Nanotechnology, Drug delivery platform, Fused Polymorph Nano Fiber Technology, Natural products, Plant-based consumables, Taste enhancement, Medical technology, Clinical testing, Novel delivery systems, CMC development, Pharmaceuticals, Healthcare innovation

No funding data available for Rexis Biotech yet.

Get notified when Rexis Biotech raises funding

Rexis Biotech Alternatives & Competitors

Rexis Biotech vs
Colyer
Colyer United Kingdom

Your print and digital technology partner.

34 employees
Consumer Goods, Design
Rexis Biotech vs
COOKE EUROPE | Morubel NV
COOKE EUROPE | Morubel NV Belgium

Leading in sustainable seafood

36 employees
Consumer Goods, Food and Beverage
Rexis Biotech vs
B Nutritious
B Nutritious United States

Newest healthy concept, NOW FRANCHISING!

5 employees
Nutrition

FAQ About Rexis Biotech

Groundbreaking Nanotechnology
Rexis Biotech was founded in 2022.
Rexis Biotech is headquartered in Las Vegas, United States.
Rexis Biotech operates in the following industries: Biotechnology, Pharmaceutical, Logistics and Delivery.
Rexis Biotech has approximately 11 employees.
Top alternatives and competitors to Rexis Biotech include Colyer, COOKE EUROPE | Morubel NV, B Nutritious , Genuine Taste, BlackHole Apk. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rexis Biotech and Colyer are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rexis Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy